Geneseo, NY, United States of America

Leah Diane Fletcher

This inventor holds 28 USPTO granted patents and 5 published patent applications, plus 6 CIPO patents and 15 EPO patents, primarily in Immunogenic Compositions. Top assignees: Wyeth Holdings Corporation, Pfizer Corporation, Serono Genetics Institute S.a.. Active years: 2003-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leah Diane Fletcher. Retrieved from https://idiyas.com/inventor/leah-diane-fletcher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 

% Patents Active = 60.7

 

 

Average Co-Inventor Count = 7.3

ph-index = 12

Forward Citations = 448(Granted Patents)


Location History:

  • Genesco, NY (US) (2020)
  • Geneseo, NY (US) (2003 - 2023)

Company Filing History:


Years Active: 2003-2023

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Immunogenic Compositions
Meningococcal Disease
Chlamydia Trachomatis
Genomic Sequence
Polypeptides
Diagnosis
Prevention
Treatment
Polynucleotides
28 patents (USPTO):Explore Patents

Title: Innovations of Leah Diane Fletcher: Contributions to Immunology

Introduction: Leah Diane Fletcher, based in Geneseo, NY, is a distinguished inventor with an impressive portfolio of 28 patents. Her work primarily focuses on compositions and methods that have significant implications in the field of immunology. Through her innovative contributions, she has enhanced our understanding and application of immune response mechanisms.

Latest Patents: Leah’s latest patents include groundbreaking compositions designed to elicit immune responses against both serogroup B and non-serogroup B strains. One notable invention comprises a factor H binding protein (fHBP) and a non-serogroup B capsular polysaccharide. This invention is pivotal for its potential uses in human populations, including adults, adolescents, toddlers, and infants. Another of her significant inventions features a composition with a first polypeptide and a second polypeptide, emphasizing a balanced molar ratio with polysorbate-80 and aluminum components. The meticulous formulation aims to induce effective bactericidal titers against various strains in human subjects through precise dosing.

Career Highlights: Leah's career is marked by her tenure at notable organizations such as Wyeth Holdings Corporation and Pfizer Corporation. Her roles in these companies have positioned her at the forefront of pharmaceutical innovations, particularly in vaccine development and immune therapeutic strategies.

Collaborations: Throughout her career, Leah Diane Fletcher has had the opportunity to collaborate with esteemed colleagues including Gary Warren Zlotnick and John Erwin Farley. These collaborations have fostered a vibrant exchange of ideas and expertise, further propelling her research and patent endeavors.

Conclusion: Leah Diane Fletcher's contributions to immunology through her patents represent a significant advancement in the quest for effective immune responses. Her work not only showcases her inventive prowess but also highlights the collaborative spirit within the scientific community. As she continues to lead in her field, the implications of her work promise to enhance public health and immunization strategies for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…